Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Hepatology · Cirrhosis of the Liver

Risk Stratification Scores and Liver Transplant Evaluation

At a Glance

MELD 3.0 helps prioritize people with cirrhosis for liver transplant using laboratory results, while Child-Pugh describes liver stability. Transplant referral may be appropriate after complications or with kidney problems, cancer, frailty, or repeated hospitalizations—even when MELD is low.

When you have cirrhosis, your care team uses mathematical models to predict the severity of your disease and determine your priority for a liver transplant. These scores are not just “grades”; they are tools that help doctors make life-saving decisions about your care [1][2].

The MELD Score: Your Transplant Priority

The Model for End-Stage Liver Disease (MELD) is the primary system used in the United States to prioritize patients for liver transplantation. It is a population-level tool designed to predict the risk of death within the next 90 days, and its score changes over time as your laboratory results change [3].

MELD-Na vs. MELD 3.0

For years, the MELD-Na score was the standard, using four variables: bilirubin (jaundice), INR (blood clotting), creatinine (kidney function), and sodium [1].

Recently, the system transitioned to MELD 3.0 to be more accurate and equitable [1][4]. MELD 3.0 includes the original four variables but adds two more:

  • Female Sex: This adjustment corrects for the fact that women often have lower creatinine levels for the same degree of kidney impairment, which previously led to lower MELD scores and longer wait times for women [1][5].
  • Albumin: This protein reflects the liver’s ability to build essential building blocks for the body [1].

MELD 3.0 also includes “interaction terms”—mathematical adjustments for how these factors affect each other, such as how bilirubin and sodium combined impact your risk [4]. It does not, by itself, determine your exact individual prognosis.

The Child-Pugh Score: Assessing Liver Stability

While MELD is used for transplant priority, the Child-Pugh (or Child-Turcotte-Pugh) score is often used at the bedside to categorize the overall stability of your liver [6]. It is a risk/stability tool that uses five factors: bilirubin, albumin, INR, and the presence/severity of ascites (fluid) and hepatic encephalopathy (confusion) [6].

  • Class A (Score 5-6): Generally the most stable disease profile.
  • Class B (Score 7-9): Significant functional impairment.
  • Class C (Score 10-15): The highest-risk disease profile [6].

Note: While Class A is often associated with “compensated” cirrhosis and Class C with “decompensated,” these terms are not perfectly interchangeable. A patient can have a decompensating event with a relatively low Child-Pugh score, and Class A patients can still have significant portal hypertension.

When to Refer for Transplant: It’s Not Just About the Score

A common mistake is waiting for a “high” MELD score before discussing a transplant. In reality, you should often be referred to a transplant center at your first major sign of decompensation (such as variceal bleeding, ascites, or severe confusion), regardless of your score [7][8]. A referral is an evaluation, not a promise of listing.

Several “red flag” situations warrant early evaluation even if your MELD score remains low:

  • Complications that MELD misses: Complications like refractory ascites (fluid that doesn’t respond to medicine), hepatic hydrothorax (fluid around the lungs), or recurrent hepatic encephalopathy significantly increase your risk of death but aren’t fully reflected in the MELD score [9][10].
  • Hepatocellular Carcinoma (HCC): If you have liver cancer that meets specific size and number criteria, you may qualify for standard exception pathways that increase your priority on the list despite a lower laboratory MELD score [11].
  • Frailty and Sarcopenia: Severe muscle loss (sarcopenia) or physical weakness (frailty) makes it harder to survive while waiting for a liver and harder to recover after surgery. Early referral allows the team to help you optimize your nutrition and strength [12][13].
  • Recurrent Admissions: If you are being hospitalized multiple times for liver issues, it is a sign that your “reserve” is low, even if your blood tests don’t look critical yet [10].

During an evaluation, transplant centers look at medical, cancer, substance-use, psychosocial, and caregiver factors to build a complete picture of your health.

The Role of Kidney Function

Kidney function is a heavy driver of MELD scores because the liver and kidneys are closely linked in advanced disease [14]. Acute Kidney Injury (AKI) or chronic kidney disease can drastically increase your MELD score. Recognizing whether kidney trouble is reversible (like hepatorenal syndrome) or permanent is a key part of the transplant evaluation [15]. In some cases, if your kidneys are severely and permanently damaged, you may be evaluated for a simultaneous liver-kidney (SLK) transplant [14][16].

Common questions in this guide

What does a MELD 3.0 score mean for someone with cirrhosis?
MELD 3.0 is a numerical score that uses laboratory results to estimate the risk of death over the next 90 days and help prioritize people for liver transplantation in the United States. The score can change as your blood test results change, and it cannot predict your exact individual outcome.
How is MELD 3.0 different from the older MELD-Na score?
MELD-Na used bilirubin, blood clotting results, kidney function, and sodium. MELD 3.0 keeps these measures and also includes albumin and an adjustment for female sex, with additional mathematical adjustments intended to improve accuracy and fairness.
When should a person with cirrhosis be referred for a liver transplant evaluation?
Referral is often appropriate after a major complication such as variceal bleeding, ascites, or severe confusion, even if the MELD score is not high. A referral starts an evaluation and does not guarantee that you will be placed on the transplant waiting list.
Can I need a transplant evaluation if my MELD score is low?
Yes. Refractory ascites, fluid around the lungs, repeated episodes of hepatic encephalopathy, liver cancer that meets transplant criteria, severe frailty or muscle loss, and recurrent hospitalizations may signal serious risk that a laboratory score does not fully capture.
What do Child-Pugh Class A, B, and C mean?
The Child-Pugh score uses bilirubin, albumin, blood clotting, ascites, and hepatic encephalopathy to describe overall liver stability. Class A generally represents the most stable profile, Class B indicates substantial impairment, and Class C represents the highest-risk profile; these classes are not perfectly interchangeable with compensated or decompensated cirrhosis.
How do kidney problems affect my cirrhosis transplant evaluation?
Acute kidney injury and chronic kidney disease can substantially raise a MELD score and affect transplant priority. The transplant team will assess whether kidney dysfunction may improve, such as with hepatorenal syndrome, or is likely permanent; severe permanent kidney damage may lead to consideration of a simultaneous liver-kidney transplant.
How do frailty and muscle loss affect liver transplant decisions?
Frailty and sarcopenia, which means loss of muscle mass, can make it harder to survive while waiting for a liver and recover after surgery. Early evaluation gives the care team time to address nutrition, physical strength, and other factors that may improve readiness for transplant.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my current MELD 3.0 score, and how does it compare to my MELD-Na score from previous visits?
  2. 2.Even though my MELD score might be low, does my history of variceal bleeding or confusion mean it's time for a transplant referral?
  3. 3.If I have kidney issues, how are those being factored into my transplant priority—am I a candidate for a simultaneous liver-kidney transplant?
  4. 4.Can we assess my 'frailty' or muscle mass formally? How do these factors impact my ability to wait for or recover from a transplant?
  5. 5.What are my Child-Pugh class and score, and what do they tell us about my liver's underlying stability?
  6. 6.Do my imaging results show any liver tumors that would qualify me for 'exception points' to boost my transplant priority?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.

    Kim WR, Mannalithara A, Heimbach JK, et al.

    Gastroenterology 2021; (161(6)):1887-1895.e4 doi:10.1053/j.gastro.2021.08.050.

    PMID: 34481845
  2. 2

    Liver transplant allocation policies and outcomes in United States: A comprehensive review.

    Latt NL, Niazi M, Pyrsopoulos NT

    World journal of methodology 2022; (12(1)):32-42 doi:10.5662/wjm.v12.i1.32.

    PMID: 35117980
  3. 3

    Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.

    Nagai S, Chau LC, Schilke RE, et al.

    Gastroenterology 2018; (155(5)):1451-1462.e3 doi:10.1053/j.gastro.2018.07.025.

    PMID: 30056096
  4. 4

    MELD 3.0 in Advanced Chronic Liver Disease.

    Mazumder NR, Fontana RJ

    Annual review of medicine 2024; (75()):233-245 doi:10.1146/annurev-med-051322-122539.

    PMID: 37751367
  5. 5

    Quantifying Sex-Based Disparities in Liver Allocation.

    Locke JE, Shelton BA, Olthoff KM, et al.

    JAMA surgery 2020; (155(7)):e201129 doi:10.1001/jamasurg.2020.1129.

    PMID: 32432699
  6. 6

    The unwell patient with advanced chronic liver disease: when to use each score?

    Moore O, Ma WS, Read S, et al.

    BMC medicine 2025; (23(1)):413 doi:10.1186/s12916-025-04185-w.

    PMID: 40629399
  7. 7

    Decompensated cirrhosis but low MELD-Should we wait or refer for liver transplantation?

    Singh N, Wong YJ, Burra P, et al.

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2025; (31(11)):1423-1432 doi:10.1097/LVT.0000000000000608.

    PMID: 40131001
  8. 8

    Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care.

    Bohra A, Worland T, Hui S, et al.

    World journal of gastroenterology 2020; (26(18)):2221-2231 doi:10.3748/wjg.v26.i18.2221.

    PMID: 32476788
  9. 9

    Hepatic Hydrothorax: A Review.

    Ismail A, Awadalla M, Pothuraju S, Singal AK

    Current hepatology reports 2025; (24(1)) doi:10.1007/s11901-025-00677-8.

    PMID: 40918209
  10. 10

    Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosis.

    Balcar L, Fromme M, Kappe N, et al.

    JHEP reports : innovation in hepatology 2025; (7(6)):101398 doi:10.1016/j.jhepr.2025.101398.

    PMID: 40535554
  11. 11

    Liver Allocation Policies in the USA: Past, Present, and the Future.

    Pillai A, Couri T, Charlton M

    Digestive diseases and sciences 2019; (64(4)):985-992 doi:10.1007/s10620-019-05549-y.

    PMID: 30895482
  12. 12

    Limitations of MELD in Isolated Polycystic Liver Disease: Fatal Traumatic Cyst Rupture Complicated by Abdominal Compartment Syndrome.

    Vinton ZC, Schulz CA, Melquist SJ, Kulig CC

    Case reports in hepatology 2026; (2026()):5849774 doi:10.1155/crhe/5849774.

    PMID: 42609653
  13. 13

    Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.

    Atiemo K, Skaro A, Maddur H, et al.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017; (17(9)):2410-2419 doi:10.1111/ajt.14239.

    PMID: 28226199
  14. 14

    Current and Evolving Indications for Simultaneous Liver Kidney Transplantation.

    Nilles KM, Levitsky J

    Seminars in liver disease 2021; (41(3)):308-320 doi:10.1055/s-0041-1729969.

    PMID: 34130337
  15. 15

    Renal Function and Transplantation in Liver Disease.

    Parajuli S, Foley D, Djamali A, Mandelbrot D

    Transplantation 2015; (99(9)):1756-64 doi:10.1097/TP.0000000000000820.

    PMID: 26308413
  16. 16

    Kidney Injury in Liver Disease.

    Regner KR, Singbartl K

    Critical care clinics 2016; (32(3)):343-55.

    PMID: 27339675

This page is for informational purposes only and does not constitute medical advice. Your liver and transplant care team must interpret your MELD and Child-Pugh results and advise whether evaluation is appropriate for you.

Get notified when new evidence is published on cirrhosis of liver.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.